China Pharma Holdings, Inc. Announces Closing of $5.0 Million Registered Direct Offering PR Newswire
Market data is delayed by at least 15 minutes.
    Latest Story
    China Pharma Holdings, Inc. Announces Closing of $5.0 Million Registered Direct Offering
     PR Newswire

    China Pharma Holdings, Inc. (NYSE American: CPHI) (the "Company"), a fully-integrated specialty pharmaceuticals company in China, today announced the closing of its previously announced registered direct offering of 2,500,000 shares of the Company's common stock, par value $0.001 per share, at a purchase price of $2.00 per share. The gross proceeds from the offering are $5 million, before deducting placement agent fees and other offering expenses. The Company intends to use the net proceeds from this offering for working capital and general corporate purposes.

    Full Story →

    Headline News
    China Pharma Holdings, Inc. Announces Closing of $5.0 Million Registered Direct Offering
    12:33a ET July 24 '26 PR Newswire
    China Pharma Announces Pricing of $5 Million Registered Direct Offering
    9:35a ET July 22 '26 PR Newswire
    China Pharma Announces Pricing of $5 Million Registered Direct Offering
    9:32a ET July 22 '26 PR Newswire
    More News →
    Day  17.84%Week  38.2%Month  147%More Charting →
    July 24 '26. Markets Closed.
    Last $1.52
    Day change   17.84%$0.33
    Open $1.78
    Gap at open $0.07
    Previous close $1.85
    Trading volume 3,703,818
    10 Day avg vol. 22,242,546
    Shares out. 43.0Mil
    Market cap. $65.4Mil
    Trading activity Below Avg.
    Previous data from yesterday, July 23 '26.

    Historical Price Performance
    3 month   158% 
    6 month   16.92% 
    1 year   19.58% 
    2 year   39.20% 

    Earnings
    Previous 12m -$0.56
    Next 12m Estimate NM
    P/E ratio --
    Revenue 4Mil

    Market data provided by News provided by